Inventiva
ALCUR.PADrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IVA337 | Phase 3 | Non-Alcoholic Steatohepatitis (NASH) | - | - |
Frequently asked questions
What is in Inventiva's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Inventiva's (ALCUR.PA) pipeline across Phase 3. Its lead program is IVA337 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Inventiva's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Inventiva (ALCUR.PA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ALCUR.PA biotech catalysts?→
Add ALCUR.PA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Inventiva's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.